Fennec Pharmaceuticals Inc
Research Fennec Pharmaceuticals Inc (FENC) on Bullrun: market cap USD 375.56M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerFENC
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 375.56M
- Financial periodQ2 2026
- RevenueUSD 17.87M
- Net incomeUSD 1.97M
- Free cash flowUSD 50.00K
- Gross margin96.0%
Valuation Snapshot
latest market cap is USD 375.56M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 44.64M | -USD 9.74B | -USD 12.47M | 91.6% | -0.34 | USD 36.79M | USD 0 | USD 35.47M |
| FY2024 | USD 47.54M | -USD 436.00M | USD 26.98M | 93.3% | -0.02 | USD 26.63M | USD 19.34M | -USD 5.87M |
| FY2023 | USD 21.25M | -USD 16.05B | -USD 17.14M | 94.1% | -0.6 | USD 13.27M | USD 30.93M | -USD 11.62M |
| FY2022 | USD 1.54M | -USD 23.71M | -USD 18.06M | 94.4% | -0.9 | USD 23.77M | USD 24.90M | -USD 2.57M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 375.56M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 263.06M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 173.97M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 299.68M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 252.10M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 114.46M | n/a | n/a | n/a |
About Fennec Pharmaceuticals Inc
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Fennec Pharmaceuticals Inc's market cap?
Fennec Pharmaceuticals Inc's market capitalization is USD 375.56M.
What does Fennec Pharmaceuticals Inc do?
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc.